MACROGENICS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $149.5M | $150.0M | $58.7M | $151.9M | $77.4M |
| Cost of revenue | $0 | $847,000 | $619,000 | $3.4M | $2.7M |
| Research and development | $147.2M | $177.2M | $166.6M | $207.0M | $214.6M |
| Operating income | -$72.8M | -$110.6M | -$168.2M | -$121.4M | -$202.8M |
| Interest expense | $8.5M | $1.1M | $1.4M | $0 | $0 |
| Pretax income | -$75.3M | -$66.0M | -$9.1M | -$119.8M | — |
| Income tax expense | -$672,000 | $944,000 | $0 | $0 | $0 |
| Net income | -$74.6M | -$67.0M | -$9.1M | -$119.8M | -$202.1M |
| Balance Sheet | |||||
| Cash and equivalents | $57.2M | $182.8M | $101.0M | $108.9M | $123.5M |
| Current assets | $219.9M | $217.5M | $251.3M | $222.2M | $279.6M |
| Total assets | $256.8M | $261.7M | $298.4M | $280.5M | $335.2M |
| Current liabilities | $43.1M | $55.5M | $56.1M | $48.6M | $74.6M |
| Total liabilities | $201.3M | $145.6M | $145.8M | $138.5M | $95.6M |
| Stockholders' equity | $55.6M | $116.1M | $152.6M | $142.0M | $239.6M |
| Cash Flow Statement | |||||
| Cash from operations | -$81.0M | -$68.4M | -$78.2M | -$87.0M | -$143.8M |
| Depreciation and amortization | $7.2M | $7.5M | $9.6M | $11.9M | $11.3M |
| Stock-based compensation | $14.3M | $29.4M | $18.4M | $20.4M | $23.1M |
| Capital expenditure | $1.9M | $3.7M | $1.8M | $3.6M | $6.2M |
| Free cash flow | -$83.0M | -$72.1M | -$80.0M | -$90.6M | -$150.0M |
| Impairments | $0 | $0 | $0 | — | — |
Shares outstanding 63.6M · Free float 98.7%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.